Literature DB >> 3972661

Dose to the contralateral breast due to primary breast irradiation.

B A Fraass, P L Roberson, A S Lichter.   

Abstract

The radiation dose received by the contralateral breast during primary breast irradiation is of concern because breast tissue is subject to cancer induction from low to moderate doses of radiation. In this paper the dose to the opposite breast has been studied in detail for common breast treatment techniques. Measurements have been made on 16 patients, a water phantom, a polystyrene phantom with cork inserts to simulate lung tissue, and a body-shaped phantom with wax breasts. Thermoluminescent dosimeters (TLD), ion chambers, diodes, and film have been used in the various configurations. The patient measurements have shown that there is a wide variation in the opposite breast dose received by patients, even when all are treated with, for example, tangential fields alone. Addition of more radiation fields, such as supraclavicular/axillary and internal mammary fields, may increase the dose to the opposite breast for a particular patient. Variations in the details of the technique such as what wedges are used, the use of blocks, and the orientation of the field edges are all important to the final dose received by the patient's contralateral breast. With the phantom measurements, it has been possible to determine the contributions to the opposite breast dose from each of the relevant factors. This makes it possible to explain the wide variation in patient dose measurements, and to make some relatively simple recommendations that will allow the reduction of the dose to the opposite breast from several hundred cGy to about 50 cGy for a typical treatment course dose of 5000 cGy.

Entities:  

Mesh:

Year:  1985        PMID: 3972661     DOI: 10.1016/0360-3016(85)90179-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy.

Authors:  Maria Tolia; Kalliopi Platoni; Andreas Foteineas; Maria-Aggeliki Kalogeridi; Anna Zygogianni; Nikolaos Tsoukalas; Mariangela Caimi; Niki Margari; Maria Dilvoi; Panagiotis Pantelakos; John Kouvaris; Vassilis Kouloulias
Journal:  World J Radiol       Date:  2011-09-28

2.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.

Authors:  Marilyn Stovall; Susan A Smith; Bryan M Langholz; John D Boice; Roy E Shore; Michael Andersson; Thomas A Buchholz; Marinela Capanu; Leslie Bernstein; Charles F Lynch; Kathleen E Malone; Hoda Anton-Culver; Robert W Haile; Barry S Rosenstein; Anne S Reiner; Duncan C Thomas; Jonine L Bernstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-14       Impact factor: 7.038

3.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

Authors:  L S Cook; E White; S M Schwartz; B McKnight; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

4.  Growth of breast cancer recurrences assessed by consecutive MRI.

Authors:  Ingrid Millet; Emmanuelle Bouic-Pages; Denis Hoa; David Azria; Patrice Taourel
Journal:  BMC Cancer       Date:  2011-04-28       Impact factor: 4.430

5.  Contralateral breast dose from partial breast brachytherapy.

Authors:  R Cole Robinson; Christopher L Nelson; Elizabeth S Bloom; Kelly D Kisling; Bryan E Mason; Gary D Fisher; Steven M Kirsner
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

6.  Characterization of a novel scale maille contralateral breast shield: SMART Armor.

Authors:  Macinley Butson; Susan Carroll; Martin Butson; Robin Hill
Journal:  J Appl Clin Med Phys       Date:  2017-08-11       Impact factor: 2.102

7.  Breast dose heterogeneity in CT-based radiotherapy treatment planning.

Authors:  R Prabhakar; G K Rath; P K Julka; T Ganesh; R C Joshi; N Manoharan
Journal:  J Med Phys       Date:  2008-04

8.  Risk of contralateral breast cancer in Denmark 1943-80.

Authors:  H H Storm; O M Jensen
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

9.  Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.

Authors:  Jonine L Bernstein; Bryan Langholz; Robert W Haile; Leslie Bernstein; Duncan C Thomas; Marilyn Stovall; Kathleen E Malone; Charles F Lynch; Jørgen H Olsen; Hoda Anton-Culver; Roy E Shore; John D Boice; Gertrud S Berkowitz; Richard A Gatti; Susan L Teitelbaum; Susan A Smith; Barry S Rosenstein; Anne-Lise Børresen-Dale; Patrick Concannon; W Douglas Thompson
Journal:  Breast Cancer Res       Date:  2004-03-09       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.